We discuss how central metabolic sensors like AMPK, mTOR, and HIF-1α oversee these metabolic shifts in response to disease-targeted pathologies in Alzheimer’s, Parkinson’s, Multiple Sclerosis, ischemic stroke, and traumatic brain injury. This evidence concerns the gene HIF1A and Parkinsonism.